Delivery Order SPE2DB22D2211-SPE2DB23FNGJ3

Award Date 5/9/23
Potential Completion Date 5/10/23
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Adderall 20 mg tablets. The award, valued at $2,810.74, is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The contract is for the supply of a wide range of medical commodities,...
This federal contract award has been issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $6,711.36, is for the delivery of Adderall 30 mg tablets to support military treatment programs and facilities globally. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to...
This federal contract award, valued at $3,540.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall 20 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $3,405.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Adderall 10 mg tablets in 100-count bottles. This delivery order falls under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC is valued at up to $999,999,999.00 and runs through November 2026,...
This is a delivery order worth $3,506.94 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Adderall 10 mg tablets. The contract has a performance period that runs through August 20, 2024 and is a firm fixed-price type. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,141.63 contract is for the delivery of Adderall 10 mg tablets to support federal healthcare programs. The contract is a firm-fixed price delivery order with a completion date of May 9, 2023. While the original solicitation details are not provided, the contract appears to be part of a larger Indefinite Delivery...
This federal contract award, valued at $1,157.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall 5 mg tablets in quantities of 100. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order worth $4,221.13 for Adderall 10 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisitions, and technical services to the U.S. military, under an existing Indefinite Delivery Contract (IDC) with the company. The IDC is valued at $999,999,999 and covers a wide range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award, valued at $1,179.14, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order, is for the supply of Adderall tablets (20mg) and has a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $6,135.00 firm fixed price delivery order is for the supply of Adderall 20 mg tablets to support military treatment programs and facilities. The award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB23FNGJ3
    Delivery Order

This federal contract award, valued at $22,908.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Adderall 20 mg tablets in 100-count packages, with a period of performance through May 10, 2023.

The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/9/25, 9:51 AM